The biopharmaceutical company researches and develops antiviral drugs used in the treatment of life-threatening diseases, including HIV and hepatitis. Last October, its intravenous drug remdesivir became the first treatment for COVID-19 approved for emergency use by the FDA.
Lists ranking Gilead Sciences
Latest news for Gilead Sciences
- HealthIn patient with long-term COVID-19, coronavirus mutated to resist antiviral RemdesivirNovember 11, 2021 9:03 AM UTC
- ConferencesGilead’s remdesivir is now used to treat half of hospitalized COVID patientsApril 28, 2021 8:40 PM UTC
- HealthGilead says remdesivir slashes coronavirus deaths. But it’s complicatedJuly 10, 2020 9:12 PM UTC